Nadezhda-3D.AI

Project summary

Project: "Hope-3D.AI"

Project presentation

https://youtu.be/73QhR7uO8CE

Digital mammography complex, with artificial intelligence, including tomosynthesis and cone beam computed tomography.

According to the World Health Organization, in 2022, breast cancer was diagnosed in 2.3 million women and caused 670,000 deaths worldwide.

Mammography is currently a very accurate and effective method of diagnosing breast cancer using X-rays. It allows you to detect cancer at the earliest stages, which can be cured. It is mammography that allows you to see abnormal tissue development two years before the doctor or the patient himself can detect such changes during palpation (with his hands).

However, existing diagnostic tools, including classical two-dimensional mammography, are inadequate, missing 35% of cancers. The miss rate increases to 70% in women with dense breasts.

  A project is proposed for the production of digital mammography complexes with artificial intelligence, including tomosynthesis and cone computed tomography, allowing you to choose a strategy for conducting an X-ray examination in order to increase diagnostic information and reduce the radiation dose to patients. The examination option (classical 2D mammography, tomosynthesis or cone computed tomography) is selected depending on the density of the breast, which is determined by artificial intelligence (neural network) based on a previous image of the breast taken at a reduced (tenfold) dose of X-ray radiation. In the case of dense mammary glands or the presence of implants, the examination is carried out using cone computed tomography. Missing projections (to reduce the dose) are generated by artificial intelligence (neural network). Analysis of 2D X-ray images, tomosynthesis layers and three-dimensional tomograms is carried out by artificial intelligence (an ensemble of neural networks).

Advantages of the proposed mammography complex:

- selection of a radiological examination strategy based on a low-dose preliminary image;

- three examination modes in one device (classical digital 2D mammography, tomosynthesis, cone beam computed tomography);

- high spatial resolution, dynamic range and contrast sensitivity;

- subtraction of X-ray images (images with contrast agent);

- biopsy;

- absence of breast compression (in cone beam computed tomography mode);

- low price of the complex.

The video shows the "Nadiya-3D" mammography complex.

https://youtu.be/L5UOwJAsSug

Unlike competitors, the proposed mammography complex allows you to choose a strategy for examining the mammary glands depending on their density, since the device has three modes (digital 2D mammography, tomosynthesis, cone beam computed tomography).

Table

The global mammography market was valued at US$2.31 billion in 2023 and is projected to reach US$5.68 billion by 2031, driven by the increase in breast cancer cases.

Sales strategy

The digital mammography complex will be sold in three versions at the following prices:

- basic $80,000;

- with additional medical monitor and printer $100,000;

- with biopsy attachment $130,000.

Grant investment:

• salary expenses $39,600;
• total costs for development, manufacturing and certification $42,000;
• administrative expenses $12,200;
• marketing company $6200.

Project roadmap:

Development and production of a mammography complex 07.2025 - 12.2025

Development and testing of a program for determining breast density 07.2025 - 11.2025

Development and testing of a program for generating intermediate projections for cone beam computed tomography and 3D image restoration 07.2025 - 12.2025

Preparation of documentation for certification 11.2025 - 01.2026

Development and testing of a program for automatic detection of microcalcifications and neoplasms in 2D images of the mammary glands 07.2025 - 01.2026

Certification in Ukraine 02.2025 - 07.2026

Development and testing of image subtraction program (images with contrast agent) 01.2026 - 07.2026

Development and testing of a breast biopsy program 01.2026 - 07.2026

Development and testing of a program for automatic detection of microcalcifications and neoplasms in images of breast layers during tomosynthesis 02.2026 - 07.2026

Development and testing of a program for automatic detection of microcalcifications and neoplasms in 3D images of the mammary glands 12.2025 -07.2026

Conducting a marketing campaign 01.2026 - 07.2026

Team:

The company "RADIOPROM" was established in 2002 as an enterprise for the development of X-ray equipment. The uniqueness of the company lies in its flexibility, constant development and the availability of a full production cycle from drawing to finished product. All our products are offered to customers with original software. Since 2002, the company has developed and supplied customers with over a thousand X-ray systems for a wide range of applications. These range from small-sized DRC-01 dosimeters that measure the dose received by a patient during an X-ray examination to 3D mammography systems and software packages using artificial intelligence to facilitate the work of personnel and improve the quality of diagnostics. The company employs a professor, a doctor of physical and mathematical sciences, and a candidate of physical and mathematical sciences.

Design engineer - development of design documentation for mammograms

Electronic engineer - development of schematic diagrams and printed circuit boards for mammograms

Researcher - development of an algorithm for tomographic reconstruction of X-ray images

Software Engineer - Software Development and Testing

Product Manager/Business Analyst - Marketing Campaign Implementation

SMM manager/designer - software development, marketing company

Radio equipment installer - assembling mammogram components